-
Je něco špatně v tomto záznamu ?
Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017)
P. Jabandziev, T. Pinkasova, L. Kunovsky, J. Papez, M. Jouza, B. Karlinova, M. Novackova, M. Urik, S. Aulicka, O. Slaby, J. Bohosova, K. Bajerova, M. Bajer, A. Goel
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dítě MeSH
- idiopatické střevní záněty * epidemiologie MeSH
- incidence MeSH
- lidé MeSH
- prospektivní studie MeSH
- ulcerózní kolitida * epidemiologie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
OBJECTIVES: Inflammatory bowel disease (IBD) is today a global disease, the incidence of which is growing in the pediatric population. This prospective study aims to decipher IBD incidence and its trend in a pediatric population through 16 years in the South Moravian Region of the Czech Republic. METHODS: We evaluated data concerning 358 pediatric patients with newly diagnosed IBD at University Hospital Brno, which is a gastroenterology center for the entire pediatric population (0-18 years) and cares for all pediatric IBD patients in the South Moravian Region (1,187,667 inhabitants). RESULTS: The study encompassed 3,488,907 children during 16 years. We diagnosed 192 children (53.6%) with Crohn disease (CD), 123 (34.4%) with ulcerative colitis (UC), and 43 (12.0%) with IBD-unclassified (IBD-U). The incidence of IBD increased from 3.8 (CD 2.9, UC 0.9, and IBD-U 0.0) per 100 000/year in 2002 to 14.7 (CD 9.8, UC 4.0, and IBD-U 0.9) per 100,000/year in 2017 (P < 0.001). The overall IBD incidence per 100,000/year was 9.8 (95% confidence interval [CI]: 8.8--10.9). Constituent incidences per 100,000/year were CD 5.2 (95% CI: 4.5--6.0), UC 3.4 (95% CI: 2.8--4.0), and IBD-U 1.2 (95% CI: 0.9--1.6). IBD incidence was projected to reach 18.9 per 100,000/year in 2022. CONCLUSIONS: The overall incidence of pediatric IBD in the Czech Republic is increasing, and especially that of CD, whereas trends in UC and IBD-U appear to be constant. These data highlight the need to identify risk factors involved in the rising incidence of IBD.
Central European Institute of Technology
Department of Gastroenterology and Internal Medicine
Department of Pathology University Hospital Brno
Department of Pediatrics University Hospital Brno
Department of Surgery University Hospital Brno
Faculty of Medicine Masaryk University
Institute of Biostatistics and Analyses Ltd Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020591
- 003
- CZ-PrNML
- 005
- 20210830102229.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MPG.0000000000002660 $2 doi
- 035 __
- $a (PubMed)32058417
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jabandziev, Petr $u Department of Pediatrics, University Hospital Brno $u Faculty of Medicine, Masaryk University $u Central European Institute of Technology
- 245 10
- $a Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017) / $c P. Jabandziev, T. Pinkasova, L. Kunovsky, J. Papez, M. Jouza, B. Karlinova, M. Novackova, M. Urik, S. Aulicka, O. Slaby, J. Bohosova, K. Bajerova, M. Bajer, A. Goel
- 520 9_
- $a OBJECTIVES: Inflammatory bowel disease (IBD) is today a global disease, the incidence of which is growing in the pediatric population. This prospective study aims to decipher IBD incidence and its trend in a pediatric population through 16 years in the South Moravian Region of the Czech Republic. METHODS: We evaluated data concerning 358 pediatric patients with newly diagnosed IBD at University Hospital Brno, which is a gastroenterology center for the entire pediatric population (0-18 years) and cares for all pediatric IBD patients in the South Moravian Region (1,187,667 inhabitants). RESULTS: The study encompassed 3,488,907 children during 16 years. We diagnosed 192 children (53.6%) with Crohn disease (CD), 123 (34.4%) with ulcerative colitis (UC), and 43 (12.0%) with IBD-unclassified (IBD-U). The incidence of IBD increased from 3.8 (CD 2.9, UC 0.9, and IBD-U 0.0) per 100 000/year in 2002 to 14.7 (CD 9.8, UC 4.0, and IBD-U 0.9) per 100,000/year in 2017 (P < 0.001). The overall IBD incidence per 100,000/year was 9.8 (95% confidence interval [CI]: 8.8--10.9). Constituent incidences per 100,000/year were CD 5.2 (95% CI: 4.5--6.0), UC 3.4 (95% CI: 2.8--4.0), and IBD-U 1.2 (95% CI: 0.9--1.6). IBD incidence was projected to reach 18.9 per 100,000/year in 2022. CONCLUSIONS: The overall incidence of pediatric IBD in the Czech Republic is increasing, and especially that of CD, whereas trends in UC and IBD-U appear to be constant. These data highlight the need to identify risk factors involved in the rising incidence of IBD.
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a ulcerózní kolitida $x epidemiologie $7 D003093
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 12
- $a idiopatické střevní záněty $x epidemiologie $7 D015212
- 650 _2
- $a prospektivní studie $7 D011446
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pinkasova, Tereza $u Department of Pediatrics, University Hospital Brno $u Faculty of Medicine, Masaryk University
- 700 1_
- $a Kunovsky, Lumir $u Faculty of Medicine, Masaryk University $u Department of Gastroenterology and Internal Medicine $u Department of Surgery, University Hospital Brno
- 700 1_
- $a Papez, Jan $u Department of Pediatrics, University Hospital Brno $u Faculty of Medicine, Masaryk University
- 700 1_
- $a Jouza, Martin $u Department of Pediatrics, University Hospital Brno
- 700 1_
- $a Karlinova, Bara $u Institute of Biostatistics and Analyses Ltd., Brno, Czech Republic
- 700 1_
- $a Novackova, Martina $u Institute of Biostatistics and Analyses Ltd., Brno, Czech Republic
- 700 1_
- $a Urik, Milan $u Faculty of Medicine, Masaryk University
- 700 1_
- $a Aulicka, Stefania $u Faculty of Medicine, Masaryk University
- 700 1_
- $a Slaby, Ondrej $u Central European Institute of Technology $u Department of Pathology, University Hospital Brno
- 700 1_
- $a Bohosova, Julia $u Central European Institute of Technology
- 700 1_
- $a Bajerova, Katerina $u Department of Pediatrics, University Hospital Brno
- 700 1_
- $a Bajer, Milan $u Department of Pediatrics, University Hospital Brno
- 700 1_
- $a Goel, Ajay $u Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA
- 773 0_
- $w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 70, č. 5 (2020), s. 586-592
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32058417 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830102229 $b ABA008
- 999 __
- $a ok $b bmc $g 1691214 $s 1141037
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 70 $c 5 $d 586-592 $e - $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
- LZP __
- $a Pubmed-20210728
